Boehringer Ingelheim International GmbH
- A10 - Antidiabéticos
- GLURENOR tablet 30 mg
- GLYXAMBI film-coated tablet 10 mg+5 mg
- GLYXAMBI film-coated tablet 25 mg+5 mg
- JARDIANCE film-coated tablet 10 mg
- JARDIANCE film-coated tablet 25 mg
- JENTADUETO film-coated tablet 1 000 mg+2.5 mg
- JENTADUETO film-coated tablet 850 mg+2.5 mg
- SYNJARDY film-coated tablet 12.5 mg+1 000 mg
- SYNJARDY film-coated tablet 12.5 mg+850 mg
- SYNJARDY film-coated tablet 5 mg+1 000 mg
- SYNJARDY film-coated tablet 5 mg+850 mg
- TRAJENTA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- ACTILYSE powder and solvent for solution for injection 50 mg+50 ml
- AGGRENOX modified-release capsule, hard 200 mg+25 mg
- METALYSE powder and solvent for solution for injection 10 000 IU
- METALYSE powder and solvent for solution for injection 6 000 IU
- METALYSE powder and solvent for solution for injection 8 000 IU
- PRADAXA capsule, hard 110 mg
- PRADAXA capsule, hard 150 mg
- PRADAXA capsule, hard 75 mg
- PRADAXA granules 110 mg
- PRADAXA granules 150 mg
- PRADAXA granules 20 mg
- PRADAXA granules 30 mg
- PRADAXA granules 40 mg
- PRADAXA granules 50 mg
- PRADAXA powder and solvent for oral solution 6.25 mg/ml
- C09 - Agentes activos sobre el sistema renina-angiotensina
- MICARDIS tablet 20 mg
- MICARDIS tablet 40 mg
- MICARDIS tablet 80 mg
- MICARDISPLUS tablet 40 mg+12.5 mg
- MICARDISPLUS tablet 80 mg+12.5 mg
- MICARDISPLUS tablet 80 mg+25 mg
- TWYNSTA tablet 40 mg+10 mg
- TWYNSTA tablet 40 mg+5 mg
- TWYNSTA tablet 80 mg+10 mg
- TWYNSTA tablet 80 mg+5 mg
- J05 - Antivirales de uso sistémico
- APTIVUS capsule, soft 250 mg
- APTIVUS oral solution 100 mg/ml
- VIRAMUNE oral suspension 10 mg/ml
- VIRAMUNE prolonged-release tablet 100 mg
- VIRAMUNE prolonged-release tablet 400 mg
- VIRAMUNE prolonged-release tablet 50 mg
- VIRAMUNE tablet 200 mg
- L01 - Antineoplásicos
- GIOTRIF film-coated tablet 20 mg
- GIOTRIF film-coated tablet 30 mg
- GIOTRIF film-coated tablet 40 mg
- GIOTRIF film-coated tablet 50 mg
- OFEV capsule, soft 100 mg
- OFEV capsule, soft 150 mg
- VARGATEF capsule, soft 100 mg
- VARGATEF capsule, soft 150 mg
- L04 - Inmunosupresores
- CYLTEZO U?PILDYTAME ?VIRK?TE solution for injection 40 mg
- CYLTEZO U?PILDYTAME ?VIRK?TIKLYJE solution for injection 40 mg
- SPEVIGO concentrate for solution for infusion 450 mg
- M01 - Antiinflamatorios y antirreumáticos
- MOVALIS solution for injection 15 mg/1.5 ml
- MOVALIS tablet 15 mg
- MOVALIS tablet 7.5 mg
- N04 - Antiparkinsonianos
- MIRAPEXIN prolonged-release tablet 0.26 mg
- MIRAPEXIN prolonged-release tablet 0.52 mg
- MIRAPEXIN prolonged-release tablet 1.05 mg
- MIRAPEXIN prolonged-release tablet 1.57 mg
- MIRAPEXIN prolonged-release tablet 2.1 mg
- MIRAPEXIN prolonged-release tablet 2.62 mg
- MIRAPEXIN prolonged-release tablet 3.15 mg
- MIRAPEXIN tablet 0.18 mg
- MIRAPEXIN tablet 0.35 mg
- MIRAPEXIN tablet 0.7 mg
- MIRAPEXIN tablet 0.88 mg
- MIRAPEXIN tablet 1.1 mg
- SIFROL prolonged-release tablet 0.26 mg
- SIFROL prolonged-release tablet 0.52 mg
- SIFROL prolonged-release tablet 1.05 mg
- SIFROL prolonged-release tablet 1.57 mg
- SIFROL prolonged-release tablet 2.1 mg
- SIFROL prolonged-release tablet 2.62 mg
- SIFROL prolonged-release tablet 3.15 mg
- SIFROL tablet 0.088 mg
- SIFROL tablet 0.18 mg
- SIFROL tablet 0.35 mg
- SIFROL tablet 0.7 mg
- SIFROL tablet 1.1 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ATROVENT N pressurised inhalation, solution 20 µg/dose
- BERODUAL N pressurised inhalation, solution 20 µg/dose+50 µg/dose
- BEROTEC N pressurised inhalation, solution 100 µg/dose
- FAVYND inhalation powder, hard capsule 18 µg
- SPIOLTO RESPIMAT pressurised inhalation, solution 2.5 µg/dose+2.5 µg/dose
- SPIRIVA inhalation powder, hard capsule 18 µg
- SPIRIVA RESPIMAT pressurised inhalation, solution 2.5 µg/dose
- SRIVASSO inhalation powder, hard capsule 18 µg
- STRIVERDI RESPIMAT pressurised inhalation, solution 2.5 µg/dosis
- YANIMO RESPIMAT pressurised inhalation, solution 2.5 µg+2.5 µg
- V03 - Todos los demás preparados terapéuticos
- PRAXBIND solution for injection 2.5 g/50 ml